Skip to main content

Table 4 Cox multivariable models for determinants of cumulative mortality

From: Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement

Tested variables

Cardiovascular mortality

All-cause mortality

HR (95% CI)

P value

HR (95% CI)

P value

Age

0.98 (0.92–1.04)

0.430

1.00 (0.95–1.06)

0.890

Male sex

1.39 (0.63–3.07)

0.409

1.50 (0.80–2.81)

0.210

BMI

0.95 (0.87–1.05)

0.334

0.97 (0.89–1.05)

0.435

Hypertension

1.04 (0.49–2.19)

0.927

0.97 (0.89–1.05)

0.929

LVEF

1.02 (0.99–1.05)

0.222

1.00 (0.98–1.02)

0.875

NT-proCNP

1.02 (1.00–1.03)

0.025

1.01 (1.00–1.03)

0.027

STS score

1.10 (1.06–1.14)

 < 0.001

1.08 (1.05–1.12)

 < 0.001

Creatinine

1.00 (0.99–1.00)

0.328

1.00 (0.99–1.00)

0.359

Access

0.58 (0.23–1.49)

0.257

0.75 (0.43–1.29)

0.291

Prosthetic valve

1.11 (0.83–1.49)

0.484

1.10 (0.85–1.36)

0.535

  1. HR, hazard ratio; CI, confidential interval
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us